More on DARE
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.71 |
|
|||
| Open | $0.70 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $0.76 | ||||
| Day Low | $0.70 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 437,484 | ||||
- Daré Bioscience gets $908K NIH grant for preterm birth program
- Daré Bioscience Announces New NIH Funding Award for Approximately $908,000 to Advance DARE-PTB2 for the Prevention of Preterm Birth
- Form SCHEDULE 13G Dare Bioscience, Inc. Filed by: Lind Global Fund III LP
- Daré Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor “Why Now” On-Demand Series
- Form S-1 Dare Bioscience, Inc.
- Daré Bioscience publishes sildenafil cream Phase 1 data in menopause journal
- Daré Bioscience’s Sildenafil Cream Data in Postmenopausal Women Published in Menopause - The Journal of The Menopause Society
- Daré Bioscience CEO discusses pipeline and commercial shift
- Daré Bioscience CEO Outlines Commercial Transformation, Pipeline Momentum and Potential Key Catalysts in Virtual Investor CEO Connect Segment
- Form SCHEDULE 13G Dare Bioscience, Inc. Filed by: L1 Capital Global Opportunities Master Fund, Ltd.
Entities mentioned with DARE
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Roth Capital | View Related Stories »
- Show More...
